Antral Follicle Diameter Variance Within Each Ovary May Be A Predictor For Poor Response In Cases With Normal Ovarian Reserve

Abstract

Objectives To determine the predictive value of antral follicle diameter variance within each ovary for ovarian response in cases with normal ovarian reserve tests.

Methods This is a prospective observational study. One hundred and thirty nine infertile women who underwent ART in IVF-ICSI unit of Zeynep Kamil women and children’s Health Training and research hospital between January 2017 to June 2017 were recruited. Blood samples were collected on day 2/day 3 for assessment of serum FSH and estradiol. Trans-vaginal sonography was done for antral follicle count. During antral follicle count, in order to determine antral follicle diameter variance, diameters of the largest and smallest follicles were recorded. Variance was calculated by subtracting the smallest diameter from the largest one. Following ovarian stimulation with antagonist protocol, poor response was determined in cases with total oocyte number≤3. Ovarian reserve tests and antral follicle diameter variance were utilized to predict cases with poor response in women with normal ovarian reserve.

Results Antral follicle diameter variance both in right (AUC=0.737, P<0.001) and left (AUC=0.651, P<0.05) ovaries significantly predicted poor ovarian response. Variance>3.5 mm was found to have 75% sensitivity to predict poor response. Basal serum FSH with estradiol levels and AFC failed to predict poor response (P>0.05). Other significant predictors for poor response were day 5 estradiol level and estradiol level at trigger day (P<0.05). In multivariate regression analysis, both AFC and antral follicle diameter variance in the right ovary were found to be significantly associated with clinical pregnancy, on the other hand peak estradiol concentration and antral follicle diameter variance in the right ovary were significantly associated with poor response.

Conclusion Antral follicle diameter variance may be utilized to predict poor ovarian response in cases with normal ovarian reserve.

Key words

Anti-mullerian hormone - Logistic regression analysis - Poor responders - Antral follicle count

• References

• 1 Jaiswar SP, Natu SM, Sujata Sankhwar PL. et al. Prediction of poor ovarian response by biochemical and biophysical markers: A logistic regression model. J Obstet Gynaecol India 2015; 65: 411-416
• 2 Ferraretti AP, La Marca A, Fauser BC. et al. ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: The Bologna criteria. Hum Reprod. 2011; 26: 1616-1624
• 3 Lai Q, Chen C, Zhang Z. et al The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol. Int J Clin Exp Pathol 2013; 6: 258-266
• 4 Cahill DJ, Prosser CJ, Wardle PG. et al. Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol. 1994; 101: 999-1002
• 5 Sharif K, Elgendy M, Lashen H. et al. Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol. 1998; 105: 107-112
• 6 Chang MY, Chiang CH, Hsieh TT. et al. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril. 1998; 69: 505-510
• 7 Tomas C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 1997; 12: 220-223
• 8 Bonilla-Musoles F, Castillo JC, Caballero O. et al. Predicting ovarian reserve and reproductive outcome using antimullerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure. Clin Exp Obstet Gynecol 2012; 39: 13-18
• 9 Haadsma ML, Bukman A, Groen H. et al. The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population. Hum Reprod 2007; 22: 1925-1931
• 10 Pohl M, Hohlagschwandtner M, Obruca A. et al. Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer. J Assist Reprod Genet 2000; 17: 315-318
• 11 Deb S, Campbell BK, Clewes JS. et al. Intracycle variance in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles. Ultrasound Obstet Gynecol 2013; 41: 216-222
• 12 Padhy N, Latha M, Sathya B. et al. Antral follicle size in the downregulated cycle and its relation to in vitro fertilization outcome. J Hum Reprod Sci 2009; 2: 68-71
• 13 Majumder K, Gelbaya TA, Laing I. et al. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol 2010; 150: 166-170
• 14 Devreker F, Pogonici E, De Maertelaer V. et al. Selection of good embryos for transfer depends on embryo cohort size: implications for the ‘mild ovarian stimulation’ debate. Hum Reprod 1999; 14: 3002-3008
• 15 Opsahl MS, Blauer KL, Black SH. et al. The number of embryos available for transfer predicts successful pregnancy outcome in women over 39 years with normal ovarian hormonal reserve testing. J Assist Reprod Genet 2001; 18: 551-556
• 16 Al-Inany H, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev. 2001; CD001750
• 17 Tan SL, Kingsland C, Campbell S. et al. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992; 57: 810-814
• 18 Cramer DW, Powers DR, Oskowitz SP. et al. Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates. Fertil Steril 1999; 72: 83-89
• 19 Fanchin R, Salomon L, Castelo-Branco A. et al. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 2003; 18: 2698-2703